Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The viral envelope membrane is a lipid bilayer that surrounds the nucleocapsid of many animal viruses, typically derived from host cell membranes during the viral budding process (Wikipedia, 2024). This structure is essential for the survival and infectivity of enveloped viruses, such as HIV, influenza, and coronaviruses, as it protects the viral genome from environmental stressors (NIH, 2023). The membrane contains viral glycoproteins that mediate host cell recognition and attachment, facilitating the fusion of the viral and host membranes to release the viral contents into the cytoplasm (StatPearls, 2023). In therapeutic applications, the viral envelope is a target for various agents; for instance, docosanol is a topical antiviral that interferes with the fusion process between the host cell and the viral envelope (PubChem, 2024). Additionally, many disinfectants like ethanol and detergents act by solubilizing the lipid bilayer, thereby inactivating the virus (CDC, 2022). Because the lipid components are host-derived, targeting the membrane itself requires careful consideration of specificity to avoid damaging host cell membranes (Journal of Virology, 2021).
Drugs targeting the viral envelope membrane typically act by disrupting the lipid bilayer structure, leading to the loss of viral integrity and infectivity, or by inhibiting the fusion process between the viral envelope and the host cell plasma membrane (PubChem, 2024; StatPearls, 2023).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Viral envelope membrane.